S&F4NTx: Smart and Fit for Kidney Transplantation

Sponsor
University of Erlangen-Nürnberg Medical School (Other)
Overall Status
Recruiting
CT.gov ID
NCT06040281
Collaborator
m&i Fachklinik Bad Heilbrunn (Other), m&i-Fachklinik Herzogenaurach (Other), Carealytix Digital Health GmbH (Other)
200
1
2
27.4
7.3

Study Details

Study Description

Brief Summary

This study is a randomised controlled intervention trial for patients with chronic kidney disease who are on the waiting list for a kidney transplantation (n=200). The aim of this study is to test the effectiveness of intensive individual nutritional and exercise support combined with comprehensive rehabilitation before transplantation in comparison to a control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: intensive individual support in nutrition and exercise
  • Behavioral: Usual Care
N/A

Detailed Description

Patients are randomised to either the intervention or control group at the beginning of the study. Both groups are evaluated at the beginning after 6 months and after 12 months regarding their body composition, physical performance, blood values, quality of life and nutritional status. The control group only receives support via app during the study period (1 year), through which they receive detailed information about dialysis. In addition to access to the app, the intervention group receives individual recommendations for nutrition and exercise as well as a three-week inpatient rehabilitation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Random assignment in 1:1 ratio to either the intervention group (app-assisted, individual support in nutrition and exercise, three-week comprehensive rehabilitation) or control group (Usual care and app-assisted)Random assignment in 1:1 ratio to either the intervention group (app-assisted, individual support in nutrition and exercise, three-week comprehensive rehabilitation) or control group (Usual care and app-assisted)
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effects of an Interdisciplinary Treatment Approach in ESRD Patients: A Randomised Controlled Trial
Anticipated Study Start Date :
Sep 18, 2023
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

App-assisted three-week comprehensive rehabilitation individual support in nutrition and exercise

Behavioral: intensive individual support in nutrition and exercise
Intensive care for nutrition and exercise adapted to the social context. Individualised exercise and nutrition recommendations. three weeks of inpatient rehabilitation with an individual plan of treatment, which includes medical care, sports therapy, physiotherapy, ergotherapy, nutritional education and psychological care App access for comprehensive information about dialysis (nutrition, travel, medication, etc.)

Active Comparator: Control

usual care App-assisted

Behavioral: Usual Care
Usual care App access for comprehensive information about dialysis (nutrition, travel, medication, etc.)

Outcome Measures

Primary Outcome Measures

  1. muscle mass [6 and 12 month]

    measured in kg by bio-impedance analysis

  2. body fat mass [6 and 12 month]

    measured in kg by bio-impedance analysis

Secondary Outcome Measures

  1. Six-Minutes-Walk test (6MWT) [6 and 12 month]

    measured in distance (meter)

  2. Sit-to-stand test (STS60) [6 and 12 month]

    measured in number of repetitions in 60 seconds

  3. Timed-up-and-go test (TUG) [6 and 12 month]

    measured in time (seconds)

  4. Quality of life by Short Form Health Survey (SF-12) [6 and 12 month]

    measured in change of scale by questionnaire

  5. Fried Frailty Scale [6 and 12 month]

    measured in change of score (score of 0 = not frail; score of 1-2 = pre-frail; score of 3-5 = frail)

  6. One-Legged Stance Test [6 and 12 month]

    measured in time (seconds)

  7. Stair Climb Test [6 and 12 month]

    measured in time (seconds)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients must be on dialysis

  • Patients ≥ 18 years of age

  • Patients who own a smartphone

  • Patients must be willing to undergo inpatient rehabilitation within the project period

  • signed informed consent and data protection regulation

Exclusion Criteria:
  • Patients who are not psychologically or physically able to take part in exercise promotion measures and/or nutritional counselling as well as psychological offers

  • Patients who have already participated in a similar project

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinikum Erlangen Erlangen Bavaria Germany 91054

Sponsors and Collaborators

  • University of Erlangen-Nürnberg Medical School
  • m&i Fachklinik Bad Heilbrunn
  • m&i-Fachklinik Herzogenaurach
  • Carealytix Digital Health GmbH

Investigators

  • Study Director: Mario Schiffer, Prof., Universitätsklinikum Erlangen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier:
NCT06040281
Other Study ID Numbers:
  • GE8-2496-IMV-2019-V2
First Posted:
Sep 15, 2023
Last Update Posted:
Sep 18, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Erlangen-Nürnberg Medical School
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 18, 2023